The government’s announcement that GC Biopharma was selected as a Phase 1 (first-stage clinical trial) support company for an ...

NEW YORK & MAINZ, GERMANY--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, ...

Dr. Albert Bourla, chairman and CEO of drugmaker Pfizer, says mRNA technology is "extremely well-tested." - Dia Dipasupil/Getty Images Pharmaceutical rivals don’t often come to each other’s defense.

Thursday, the FDA granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP ...

Two scientists won the Nobel Prize in medicine for research that laid the groundwork for some of the best-selling medicines of all time: the messenger-RNA vaccines against COVID-19. Katalin Kariko and ...

Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep your expectations in check.

As your immunity wanes from previous infection and vaccination, the best way to protect yourself against COVID-19 is to get the new COVID vaccine. There are three currently available — is one better ...

The race is on—again. Having already gone up against Moderna in COVID-19 and influenza, Pfizer and BioNTech have now followed their recurring rival in reporting early-phase data on an mRNA combination ...

Expands Pfizer’s access to lipid nanoparticle (LNP) formulation technology, offering a strong strategic fit with Pfizer’s mRNA strategy Pfizer gains option to license Acuitas’ LNP technology for up to ...

Moderna and Pfizer are each in the process of competing for federal contracts to build a national stockpile of mRNA vaccines targeted toward the new bird flu amid mounting concerns it may be spreading ...

An additional dose can increase protection against severe disease, CDA said. Read more at straitstimes.com. Read more at ...

Dr. Moritz Eidens will be speaking about a novel and non-invasive mRNA and AI based early Colorectal Cancer and Advanced Adenoma detection approach. Dr. Eidens will be presenting a detailed first ...